This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2017 Jun 29;376(26):2598.

doi: 10.1056/NEJMc1705868.

Regulatory Review of New Therapeutic Agents

Yasuhiro Fujiwara¹, Shunsuke Ono²

Affiliations

Affiliations

¹ National Cancer Center, Tokyo, Japan yfujiwar@ncc.go.jp
² University of Tokyo Graduate School of Pharmaceutical Sciences, Tokyo, Japan

PMID: 28691786
DOI: 10.1056/NEJMc1705868

Comment

Regulatory Review of New Therapeutic Agents

Yasuhiro Fujiwara et al. N Engl J Med. 2017.

. 2017 Jun 29;376(26):2598.

doi: 10.1056/NEJMc1705868.

Authors

Yasuhiro Fujiwara¹, Shunsuke Ono²

Affiliations

¹ National Cancer Center, Tokyo, Japan yfujiwar@ncc.go.jp
² University of Tokyo Graduate School of Pharmaceutical Sciences, Tokyo, Japan

PMID: 28691786
DOI: 10.1056/NEJMc1705868

No abstract available

PubMed Disclaimer

Comment in

Regulatory Review of New Therapeutic Agents.
Downing NS, Zhang AD, Ross JS. Downing NS, et al. N Engl J Med. 2017 Jun 29;376(26):2598. doi: 10.1056/NEJMc1705868. N Engl J Med. 2017. PMID: 28657868 No abstract available.

Comment on

Regulatory Review of New Therapeutic Agents - FDA versus EMA, 2011-2015.
Downing NS, Zhang AD, Ross JS. Downing NS, et al. N Engl J Med. 2017 Apr 6;376(14):1386-7. doi: 10.1056/NEJMc1700103. N Engl J Med. 2017. PMID: 28379798 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations